While this is not a reason to take retatrutide, it is a potential secondary benefit that athletically inclined researchers may notice
(Physicians will likely stop prescribing a GLP-1 or dual agonist if you receive a pancreatitis diagnosis.) Your doctor should also reevaluate treatment and dosage if you have any other severe side effects
Overview Since their approval, the labels for anti-obesity GLP-1s (Zepbound, Wegovy, and Saxenda) have included warnings about the potential risk for suicidal ideation and instruct healthcare providers to monitor patients and discontinue use if they experience suicidal thoughts or behaviors
Retatrutide and Body Composition Detailed body composition data from the retatrutide Phase 2 trial has not been fully published
Conflicts of Interest: From the study, A.J.S
The FDA requires a black box warning about seizure risk (higher with high-fat meals, alcohol, or abrupt alcohol withdrawal) and about neuropsychiatric effects from bupropion including changes in mood, behavior, or suicidal thoughts
